InvestSMART

Adheris Health Limited (ASX:AHE)

ALERT: Price-sensitive ASX Announcement for AHE
Current share price for AHE : $0.014 -0.004 (-22.22%)+
Release
31 Jul 2026 3:32PM
Price at Release
$0.018
Full Release
download
Summary
Adheris Health Limited, trading on ASX as AHE, is engaged in a legal dispute with Mindsprint Pte. Ltd. in the United States District Court for the Southern District of New York. The dispute arises from the termination of a Master Services Agreement and related statements of work, which Mindsprint alleges was done unfairly and should be treated as a termination for convenience. Mindsprint is seeking damages of at least US$2.3 million plus costs. Adheris, on the other hand, considers the terminations valid for cause and intends to contest the claims. The case is in its early stages, and Adheris does not foresee any operational impact or immediate financial consequences, though it will continue to honor its disclosure obligations.
Key Points
  • Adheris Health Limited (ASX: AHE) is involved in a legal proceeding initiated by Mindsprint Pte. Ltd.
  • The proceedings are taking place in the United States District Court for the Southern District of New York.
  • Mindsprint provided IT development and managed services to Adheris under a Master Services Agreement started on August 15, 2025.
  • Adheris terminated the agreement and related statements of work for cause in May and June 2026.
  • Mindsprint claims breach of contract, seeks a declaratory judgment for termination for convenience, and demands damages of at least US$2.3 million plus costs.
  • Adheris disputes the claims and plans to defend the proceedings vigorously.
  • The legal proceedings are at an early stage, and the financial impact cannot be reliably quantified.
  • The company states the proceedings are not expected to impact its operations and will provide updates as necessary under ASX Listing Rule 3.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.